Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

33%(1 trials)

Phase Distribution

Ph not_applicable

75%

Ph phase_2

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Other(1)

Detailed Status

Completed3

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (25.0%)

N/A3 (75.0%)

Trials by Status

unknown125%

completed375%

Recent Activity

0 active trials

Showing 4 of 4

completednot_applicable

Irritation Potential of Omeza Collagen Matrix Using Modified HRIPT

NCT04510675

completednot_applicable

Skin Protectant Properties of Omeza Collagen Matrix on Damaged Skin

NCT04512274

completednot_applicable

Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method

NCT04510376

unknownphase_2

Osteoarthritis of the Knee Pain Study Using a CBD and THC Sublingual Tablet

NCT04195269

Clinical Trials (4)

Showing 4 of 4 trials

NCT04510675Not Applicable

Irritation Potential of Omeza Collagen Matrix Using Modified HRIPT

Completed

NCT04512274Not Applicable

Skin Protectant Properties of Omeza Collagen Matrix on Damaged Skin

Completed

NCT04510376Not Applicable

Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method

Completed

NCT04195269Phase 2

Osteoarthritis of the Knee Pain Study Using a CBD and THC Sublingual Tablet

Unknown

All 4 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 4